Susan Molineaux is PRESIDENT & CEO of Calithera Biosciences, Inc.. Currently has a direct ownership of 95,000 shares of CALA, which is worth approximately $0. The most recent transaction as insider was on Jan 20, 2021, when has been sold 85,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95K
0% 3M change
0% 12M change
Total Value Held $0

Susan Molineaux Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2021
BUY
Grant, award, or other acquisition
-
85,000 Added 47.22%
95,000 Common Stock

Also insider at

TBPH
Theravance Biopharma, Inc. Healthcare
GERN
GERON CORP Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
SM

Susan Molineaux

PRESIDENT & CEO
South San Francisco, CA

Track Institutional and Insider Activities on CALA

Follow Calithera Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CALA shares.

Notify only if

Insider Trading

Get notified when an Calithera Biosciences, Inc. insider buys or sells CALA shares.

Notify only if

News

Receive news related to Calithera Biosciences, Inc.

Track Activities on CALA